Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Login to our social questions & Answers Engine to ask questions answer people’s questions & connect with other people.
Lost your password? Please enter your email address. You will receive a link and will create a new password via email.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Questions | Answers | Discussions | Knowledge sharing | Communities & more.
The Serum Institute of India (SII) has begun exporting the ‘R21/Matrix-M’ malaria vaccine to Africa to combat the disease. This new vaccine, recommended by WHO, joins the RTS,S/AS01 vaccine. Developed by Oxford University’s Jenner Institute and SII, it received support from EDCTP, Wellcome Trust, and EIB. Affordable and effective, it’s approved for children and licensed in multiple African countries, marking a significant step in global malaria prevention efforts.